Cargando…

Probiotics do not significantly reduce nosocomial pneumonia

Detalles Bibliográficos
Autores principales:	Silvestri, Luciano, van Saene, Hendrick KF, Gregori, Dario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672561/ https://www.ncbi.nlm.nih.gov/pubmed/23140474 http://dx.doi.org/10.1186/cc11654

Ejemplares similares

Selective digestive decontamination is superior to selective oropharyngeal decontamination
por: Silvestri, Luciano, et al.
Publicado: (2011)

Withholding selective decontamination of the digestive tract from critically ill patients must now surely be ethically questionable given the vast evidence base
por: Zandstra, Durk F, et al.
Publicado: (2010)

Antifungal prophylaxis in critically ill patients
por: Silvestri, Luciano, et al.
Publicado: (2008)

Selective digestive decontamination saves lives whilst preventing resistance
por: Silvestri, Luciano, et al.
Publicado: (2015)

Oral decontamination with chlorhexidine reduces the incidence of nosocomial pneumonia
por: Siempos, Ilias I, et al.
Publicado: (2007)

A case of Corynebacterium pseudodiphtheriticum nosocomial pneumonia.
por: Martaresche, C, et al.
Publicado: (1999)

The role of probiotics in nosocomial infections
por: Zuccotti, Gian Vincenzo, et al.
Publicado: (2014)

Reducing the Risk for Waterborne Nosocomial Neonatal Legionellosis
por: Cervia, Joseph S.
Publicado: (2015)

Nosocomial septicemia in COVID-19 nosocomial K. pneumoniae, A. baumannii, and Elizabethkingia meningoseptica septicemia in a patient of COVID-19
por: Ong, Jie Ywi, et al.
Publicado: (2022)

Selective decontamination of the digestive tract: an update of the evidence
por: Silvestri, L, et al.
Publicado: (2012)

Probiotics' effects on the incidence of nosocomial pneumonia in critically ill patients: a systematic review and meta-analysis
por: Liu, Kai-xiong, et al.
Publicado: (2012)

Community-acquired and nosocomial pneumonia
por: Herold, Christian J., et al.
Publicado: (2004)

Ceftolozane-tazobactam in nosocomial pneumonia
por: Candel, Francisco Javier, et al.
Publicado: (2022)

Trichosporon asahii as Cause of Nosocomial Pneumonia in Patient With COVID-19: A Triple Co-infection
por: Segrelles-Calvo, Gonzalo, et al.
Publicado: (2021)

Can the use of probiotics reduce the incidence of nosocomial Clostridium difficile infection in 60 years or older patients?
por: Jani, Akash, et al.
Publicado: (2018)

Nosocomial Transmission of Dengue
por: Nemes, Zsuzsanna, et al.
Publicado: (2004)

Probiotics and Prebiotics: Role in Prevention of Nosocomial Sepsis in Preterm Infants
por: Nair, Vrinda, et al.
Publicado: (2013)

Current treatment of nosocomial pneumonia and ventilator-associated pneumonia
por: Plata-Menchaca, Erika P., et al.
Publicado: (2022)

Nosocomial pneumonia in critically ill patients
por: Dandagi, Girish L.
Publicado: (2010)

Treating nosocomial pneumonia: what's new
por: Frantzeskaki, Frantzeska, et al.
Publicado: (2018)

Update of the treatment of nosocomial pneumonia in the ICU
por: Zaragoza, Rafael, et al.
Publicado: (2020)

Erratum: Ceftolozane-tazobactam in nosocomial pneumonia
por: FJ, Candel, et al.
Publicado: (2022)

Nosocomial Infections: Do Not Forget the Parasites!
por: Fürnkranz, Ursula, et al.
Publicado: (2021)

The Most Important Species of Nosocomial Infection and the Most Important Wards Susceptible to Nosocomial Infection
por: FARZIANPOUR, Fereshteh, et al.
Publicado: (2014)

Nosocomial outbreak of multi-resistant Streptococcus pneumoniae serotype 15A in a centre for chronic pulmonary diseases
por: Bastiaens, Guido J. H., et al.
Publicado: (2018)

Nosocomial Dengue by Mucocutaneous Transmission
por: Chen, Lin H., et al.
Publicado: (2005)

Efficacy of inhaled tobramycin in severe nosocomial pneumonia
por: Kuzovlev, A, et al.
Publicado: (2012)

Nosocomial Pneumonia: Rationalizing the Approach to Empirical Therapy
por: Andriesse, Gunnar I., et al.
Publicado: (2012)

Specific multigenotypic diagnosis of nosocomial pneumonia in ICU
por: Pirard, M, et al.
Publicado: (2001)

Ameba-associated Microorganisms and Diagnosis of Nosocomial Pneumonia
por: Berger, Pierre, et al.
Publicado: (2006)

Inhaled tobramycin for the treatment of nosocomial pneumonia in sepsis
por: Kuzovlev, A, et al.
Publicado: (2014)

Shewanella putrefaciens: An Emerging Cause of Nosocomial Pneumonia
por: Ullah, Saad, et al.
Publicado: (2018)

Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia
por: Jean, Shio-Shin, et al.
Publicado: (2020)

Respiratory Viruses in Nosocomial Pneumonia: An Evolving Paradigm
por: Zilberbeg, Marya D., et al.
Publicado: (2023)

Possible Nosocomial Transmission of Pneumocystis jirovecii
por: Damiani, Céline, et al.
Publicado: (2012)

Prevention of nosocomial COVID-19: Another challenge of the pandemic
por: Van Praet, Jens T., et al.
Publicado: (2020)

Analysis of adherence to national nosocomial pneumonia treatment guidelines
por: Eiland, Edward H, et al.
Publicado: (2007)

Bacteremic nosocomial pneumonia cases from the ATTAIN studies
por: Rubinstein, E, et al.
Publicado: (2010)

On the diagnosis of acute respiratory distress syndrome in nosocomial pneumonias
por: Kuzovlev, A, et al.
Publicado: (2010)

Nosocomial pneumonia in medico-surgical intensive care unit.
por: Chung, K. I., et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_hufteuf1hhnncme1m019nb1b7c